Cochrane Clinical Answers
Cochrane Clinical Answers (CCAs) provide a readable, digestible, clinically focused entry point to rigorous research from Cochrane systematic reviews. They are designed to be actionable and to inform decision making at the point of care and have been added to relevant sections of the main Best Practice text.
- How does respiratory syncytial virus (RSV) vaccination during pregnancy affect mothers and infants?
- What are the effects of rapid viral detection tests for children attending emergency departments with an acute respiratory infection?
- What are the effects of bronchodilators in infants with bronchiolitis?
- What are the benefits and harms of antibiotics in children with bronchiolitis?
- In infants and young children with acute viral bronchiolitis, what are the effects of glucocorticoids?
- In infants with bronchiolitis, is there randomized controlled trial evidence to support the use of heliox inhalation therapy?
- How does montelukast affect outcomes in children up to 24 months of age hospitalized with bronchiolitis?
- What are the effects of immunoglobulins for hospitalized infants with respiratory syncytial virus (RSV) infection?
Use of this content is subject to our disclaimer